Healthcare Business Intelligence Market - 2024-2033

December 2025 | 219 pages | ID: H863608AB846EN
DataM Intelligence

US$ 2,999.00 US$ 4,350.00 -31 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Healthcare Business Intelligence Market was valued at US$ 8.51 billion in 2024 and is anticipated to reach US$ 16.53 billion by 2033, at a CAGR of 0.075 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Healthcare Business Intelligence Market.

This report delivers a comprehensive overview of the Healthcare Business Intelligence Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Healthcare Business Intelligence Market. The Healthcare Business Intelligence Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Healthcare Business Intelligence Market Scope:

By Component
  • Software
  • Platforms
  • Services
By Functionality
  • Query and Reporting
  • OLAP (Online Analytical Processing) and Visualization
  • Performance Management
  • Data Integration and ETL (Extract, Transform, Load)
By Deployment
  • On-Premise
  • Cloud-Based
By Application
  • Clinical Analytics
  • Financial Analytics
  • Operational Analytics
By End User
  • Hospitals and Clinics
  • Healthcare Providers
  • Payers (Insurance Companies)
  • Pharmaceutical and Biotechnology Companies
Key Players
  • IBM Corporation
Major Highlights

This report delivers a comprehensive overview of the Healthcare Business Intelligence Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Healthcare Business Intelligence Market. The Healthcare Business Intelligence Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
  • Increase Your Customer Base by 3X using our Partner Identification tool
  • Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
  • Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
  • Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Component
3.2. Snippet by Functionality
3.3. Snippet by Deployment
3.4. Snippet by Application
3.5. Snippet by End User
3.6. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rise in the Adoption of Advanced Technologies
    4.1.1.2. XX
  4.1.2. Restraints
    4.1.2.1. High Implementation Costs
  4.1.3. Opportunity

5. IMPACT ANALYSIS

6. INDUSTRY ANALYSIS

6.1. Porter’s Five Force Analysis
6.2. Supply Chain Analysis
6.3. Pricing Analysis
6.4. Regulatory Analysis

7. BY COMPONENT

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  7.1.2. Market Attractiveness Index, By Component
7.2. Software*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Platforms
7.4. Services

8. BY FUNCTIONALITY

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  8.1.2. Market Attractiveness Index, By Functionality
8.2. Query and Reporting*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. OLAP (Online Analytical Processing) and Visualization
8.4. Performance Management
8.5. Data Integration and ETL (Extract, Transform, Load)

9. BY DEPLOYMENT

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  9.1.2. Market Attractiveness Index, By Deployment
9.2. On-Premise*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cloud-Based

10. BY APPLICATION

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.1.2. Market Attractiveness Index, By Application
10.2. Clinical Analytics*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Financial Analytics
10.4. Operational Analytics

11. BY END USER

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals and Clinics*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Healthcare Providers
11.4. Payers (Insurance Companies)
11.5. Pharmaceutical and Biotechnology Companies

12. BY REGION

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  12.1.2. Market Attractiveness Index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.2.8.1. U.S.
    12.2.8.2. Canada
    12.2.8.3. Mexico
12.3. Europe
  12.3.1. Introduction
  12.3.2. Key Region-Specific Dynamics
  12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.3.8.1. Germany
    12.3.8.2. U.K.
    12.3.8.3. France
    12.3.8.4. Spain
    12.3.8.5. Italy
    12.3.8.6. Rest of Europe
12.4. South America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.4.8.1. Brazil
    12.4.8.2. Argentina
    12.4.8.3. Rest of South America
12.5. Asia-Pacific
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.5.8.1. China
    12.5.8.2. India
    12.5.8.3. Japan
    12.5.8.4. South Korea
    12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
  12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. COMPANY PROFILES KEY MARKET PLAYERS

14.1. IBM Corporation*
  14.1.1. Company Overview
    14.1.1.1. Product Portfolio
      14.1.1.1.1. Product Description
      14.1.1.1.2. Product Key Performance Indicators (KPIs)
      14.1.1.1.3. Historic and Forecasted Product Sales
      14.1.1.1.4. Product Sales Volume
    14.1.1.2. Financial Overview
      14.1.1.2.1. Company Revenue’s
      14.1.1.2.2. Geographical Revenue Shares
      14.1.1.2.3. Revenue Forecasts
    14.1.1.3. Key Developments
      14.1.1.3.1. Mergers & Acquisitions
      14.1.1.3.2. Key Product Development Activities
      14.1.1.3.3. Regulatory Approvals etc.
    14.1.1.4. SWOT Analysis
  14.1.2. Microsoft Corporation
  14.1.3. Oracle Corporation
  14.1.4. SAS Institute Inc
  14.1.5. Tableau Software (Salesforce)
  14.1.6. SAP SE
  14.1.7. Qlik Technologies, Inc
  14.1.8. Infor, Inc
  14.1.9. MicroStrategy Incorporated
  14.1.10. Sisense Inc * Similar data will be provided for each market player. Emerging Market Players

15. DOMO, INC*

15.1. Pipeline Products Description
  15.1.1. Product Key Performance Indicators (KPIs)
  15.1.2. Key Activities
  15.1.3. Market Entry Timelines
  15.1.4. Product Penetration Rate
  15.1.5. Sales Estimation and Projections
15.2. Yellowfin BI
15.3. Datapine GmbH * Similar data will be provided for each market player.LIST NOT EXHAUSTIVE

16. APPENDIX

16.1. About Us and Services
16.2. Contact Us


More Publications